Alnylam Pharmaceuticals (ALNY) Q2 2017 Results - Earnings Call Transcript
Earnings

ALNY Beats EPS Loss Estimates By $0.10. Misses On Revenues.

Alnylam Pharmaceuticals (ALNY) Q2 2017 Results – Earnings Call Transcript ALNY Beats EPS Alnylam Pharmaceuticals (NASDAQ:ALNY): Q2 EPS of -$1.07 beats by $0.15. Revenue of $15.9M (+82.5% Y/Y) misses by $6.41M. Executives Christine Regan Lindenboom – Alnylam Pharmaceuticals, Inc. John M. Maraganore, Ph.D. – Alnylam Pharmaceuticals, Inc. Akshay K. Vaishnaw – Alnylam Pharmaceuticals, Inc. Manmeet Singh Soni […]